The global COVID-19 pandemic

Ibtisam Jasim Sodani, Ahmed A. Mhawesh, Mayyahi Mohammed T. Jaber

1-Molecular Genetics and Finger Printing Department, Forensic DNA Centre for Research and Training, AL-Nahrain University, Baghdad, Iraq.
2-Dept. of Med. and Mol. Biotech. Coll. of Biotech – Al-Nahrain University, Iraq
3-Forensic DNA Research and Training Center, AL-Nahrain University, Iraq

alshammariahmed.a.m@gamil.com

Article History : Received: Nov 5, 2020 / Revised: Dec 8, 2020/ Accepted: Dec 12, 2020

Abstract

The Chinese government at the end of 2019, informed the World Health Organization (WHO) that many cases of uncommon etiology pneumonia have been investigated in the Hunan seafood market and infected more than fifty persons. This seafood market sold snakes, bats, frogs, birds, marmots, and many other animals. On 12 January 2020, the National Health Commission of China released information concerning this outbreak, proposed that the causative agent of pneumonia is viral. However, depending on the genetic sequence and the sequence-based analysis of specimens of the infected patients, the diagnosed virus was named Coronavirus. WHO officially stated on 30 January 2020, that the coronavirus disease (COVID-19) outbreak as an international health emergency was rapidly extended throughout China. Europe has also become a new epicenter of COVID-19. These cases have been spread across the world with the worst situations reported in Italy. As per the WHO report on March 17, 2020, the cases outside China have exceeded. However, investigations revealed that this viral disease could be transmitted from human to human. Meanwhile the common symptoms of this viral disease involved, sore throat, fever, fatigue, cough with shortness of breathing. The greatest cases showed mild symptoms, while other cases exhibit progress to pneumonia and multi-organ failure particularly in patients suffering from underlying diseases and the elderly.

Keywords Acute Respiratory Disease, Pneumonia, Coronavirus Infection, Viral Diseases, Pandemic Diseases.

How to cite this article  Sodani, I.J., Mhawesh A. A., Jaber, M.M.T. (2020). The global COVID-19 pandemic. Science Archives, 1 (3), 70-83.

Crossref DOI

http://dx.doi.org/10.47587/SA.2020.1301

Copyright

This is an open-access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

Adachi, D., Johnson, G., Draker, R., et al. (2004). Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. J Virol Method, 122, 29-36.

Adnan, S.h. M., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: origin, transmission, and characteristics of human coronaviruses, Journal of Advanced Research.

 Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., … & Xia, L. (2020). Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 200642.

Ajlan, A. M., Ahyad, R. A., Jamjoom, L. G., Alharthy, A., & Madani, T. A. (2014). Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. American journal of roentgenology, 203 (4), 782-787.

Alexopoulou, L., Holt, A.C., Medzhitov, R., & Flavell, R.A. (2001). Recognition of double stranded RNA and activation of NF- kappa B by toll-like receptor 3. Nature, 413 (6857), 732-8. 

Arunrut,  N., Kampeera, J., Sirithammajak,  S., Sanguanrut,  P., et al. (2016). Sensitive visual detection of AHPND bacteria using loop-mediated isothermal amplification combined with DNA- functionalized gold nanoparticles as probes. PLOS One, 11 (3), e 0151769.

 Atkinson, J., Chartier, Y., Pessoa-Silva, C.L., Jensen, P., Li, Y., Seto, W.H., editors. (2020). Natural ventilation for infection control in health-care settings. Geneva: World Health Organization; 2009. Annex C, Respiratory droplets. Available at: https://www.ncbi.nlm.nih. gov/books/NBK143281/. Last accessed: March 25, 2020.

Bai, Y., Yao, L., Wei, T., Tian, F., Jih, D.Y., Chen, L., et al. (2020). Presumed asymptomatic carrier tratnsmission of COVID-19. JAMA. 2020 Feb 21.

Balboni, A., Gallina, L., Palladini, A., Prosperi, S., Battilani, M. (2012). A real-time PCR assay for bat SARS-like coronavirus detection and its application to Italian greater horseshoe bat faecal sample surveys. Scientific World J, 989514

Bartscher, M., Hilpert, U., Goebbels, J., Weidemann, G., (2007). Enhancement and proof of accuracy of industrial computed tomography (ct) measurements. Annals of CIRP, 56 (1), 495- 498.

Becker, M.M. et al. (2008). Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl Acad. Sci. USA105: 19944- 19949

Beniac, D.R., de Varennes,  S.L., Andonov, A., He,  R., Booth, T.F. (2007). Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion. PLoS ONE,2, e1082

Binnicker, M.J. (2020). Emergence of a novel coronavirus disease (COVID-19) and the importance of diagnostic testing: Why partnership between clinical laboratories, public   health agencies and industry is essential to control the outbreak. Clin Chem.

Bonilla-Aldana, D.K., Suarez J.A., Franco-Paredes, C., Vilcarromero, S. et al., (2019). Brazil burning! What is the potential impact of the Amazon wildfires on vector-borne and zoonotic emerging diseases? A statement from an international experts meeting. Travel Med. Infect. Dis, 31/ 101474

Cai, G. (2020). Tobacco- Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCov. 

Cameron, M.J., Bermejo-Martin, J. F., Danesh, A.  et al. (2008). Human immunopatho-genesis of severe acute respiratory syndrome (SARS), Virus Res, 133, 13-19.

Cao, M., Zhang, D., Wang, Y., et al. (2020). Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China. Med Rxiv. 

 Cao, Z., Liu, L., Du, L., et al. (2010). Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients. Virol J. 7(1), 299 

Cavanagh, D. (1995). The coronavirus surface glycoprotein. In “The Coronaviridae” (S. G. Siddell, ed). pp. 73–113. New York: Plenum Press,

Centers for Disease Control and Prevention (2020). Coronavirus Disease 2019 (COVID-19). Archived from the original on 14 February 2020. Retrieved 31 March 2020

 Chang, Xu, H., Rebaza, A., Sharma, L., Dela, Cruz, C.S. (2020). Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med.Feb 13.

Channappanavar, R.S., Perlman (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin. Immunopathol, 39, 529-539 

Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020). Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis.. doi: 10.1016/S1473- 3099(20)30141-9. 

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395, 507-13. 

Chu, D.K.W., Pan, Y., Cheng, S.M.S.  et al.  (2020). Molecular Diagnosis of a Novel Coronavirus (2019 – nCoV) Causing an Outbreak of Pneumonia, Clin Chem.

Corman, V.M, .  Landt, O., Kaiser, M. et al. (2020). Detection of 2019 novel coronavirus (2019 – nCoV) by real-time RT- PCR, Euro. Surveill. Vol. 25

Cornelis, A.M., Peter, J.M. (2005). Rottier. Molecular interactions in the assembly of coronaviruses.   Advances in Virus Research.  64: 165-230

Cui, J., Li, F., Shi, Z.L. (2019): Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 17(3), 181–92.

 Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV). Testing in Europe. Globe News wire News Room.

Dan, H., Maureen, G., Richard, B., et al. (2002).  Quantitative mRNA expression of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS.

de Groot,  R.J., Lenstra,  J.A., Luytjes,  W., Niesters,  H.G., Horzinek,  M.C., van der Zeijst,  B.A.   Spaan, W.J. (1987a). Sequence and structure of the coronavirus peplomer protein. Adv. Exp. Med. Biol, 218, 31–38.

de Wilde, A.H., Snijder, E.J., Kikkert, M., van Hemert, M.J. (2018). Host factors in coronavirus replication. Curr Top Microbiol  Immunol,  419,  1- 42.

Ding, Y., Wang,H., Shen,  H., Li,  Z., Geng, J., Han,  H., Cai,  J., Li,  X., Kang, W. et al. (2003). The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J. Pathol, 200, 282- 289.

Ellwanger, J.H., Chies, J.A.B. (2018). Zoonotic spillover and emerging viral diseases – time to intensify zoonoses surveillance in Brazil. Braz. J. Infect. Dis, 22 (1), 76- 78.

Enosawa, M., Kageyama, S., Sawai, K., et al. (2003). Use of loop- mediated isothermal amplification of the IS900 sequence for rapid detection of cultured Mycobacterium avium subsp. paratuberculosis. J Clin Microbiol, 41, 4359- 65

European Centre for Disease Prevention and Control. Available at:https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed on March 17:  2020.

 Fan, C., Li, K., Ding, Y., Lu, W.L., Wang. J. (2020).ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection. med Rxiv.

Fei, Zhou, T.Y., Ronghui, D., Guohui, F., Ying, L., Zhibo, L., Jie, X. (2020). Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 March 9, 2020.

Fellmann, F. (2020). (In German) Jetzt beginnt die Suche nach den Genesenen. Tages Anzeiger. Retrieved 28 March 2020.  

Food and Drug Administration(2020). Just Okayed multiple 15-minute blood tests to screen for coronavirus, but there are caveats. Techcrunch.com. 27 March 2020.

Fu, Y., Cheng, Y., Wu, Y. (2020). Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virol Sin.

Ganyani, T., Kremer, C., Chen, D., Torneri, A., Faes, C., Wallinga, J., et al.(2020). Estimating the generation interval for COVID-19 based on symptom onset data. Med Rxiv.

Ge, X.Y., Li, J.L. Yang, X.L. et al. (2013). Isolation and characterization of a bat SARS-like coronavirus uses the ACE2 receptor. Nature, 503, 535-538.

General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine (2020).  Diagnostic and treatment protocol for Novel Coronavirus Pneumonia; (Trial version 6).  (Accessed on 20 February 2020).

Glowacka, I., Bertram, S., Müller, M.A., Allen, P., Soilleux, E., Pfefferle, S., et al. (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of virology, 85(9), 4122-34.

Guan, W.J., Ni, Z.Y., Hu, Y., Laing, W.H., Ou, C.Q., He, J.X., et al.(2020). Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv.2020 Feb 9. 

Guo, Y-R., Cao, Q-D., Hong, Z-S., et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak: an update on the status. Mil Med Res, 7:11

Hamming, I., Timens, W., Bulthuis, M.L., Lely, A.T., Navis, G., van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol.  203(2): 631–7.

Hessen, M.T. (2020). Novel Coronavirus Information Center: Expert guidance and commentary. Elsevier Connect. Archived from the original on 30 January 2020.

Holshue,  M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. (2020). First Case of  2019 Novel Coronavirus in the United States. N Engl J Med.

https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.   

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497-506. 

Hui, D.S., I Azhar, E., Madani, T.A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G. et al., (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 91, 264-266.

Imai, Y., Kuba, K., Penninger, J.M. (2008). The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol, 93, 543- 548.

Jia, H.P., Look, D.C., Shi, L., Hickey, M., Pewe, L., Netland, J., et al. (2005). ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 79 (23), 14614- 21.

Jin, Y., Cai, L., Cheng, Z. et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res. 7 (4) 

Kuiken, T., Fouchier, R.A., Schutten, M., Rimmelzwaan, G.F., Van Amerongen, G., van Riel, D., Laman, J.D., de Jong, T., van Doornum, G., Lim, W. (2003). Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet, 362(9380), 263-270.

Lai, C-C., Liu, Y.H., Wang, C-Y., Wang, Y-H., Hsueh, S- C., Yen, M-Y. et al.(2020). Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths, Journal of Microbiology, Immunology and Infection. 25 February 2020

Laude, H., Masters, P.S. (1995). Coronavirus nucleocapsid protein. In “The Coronaviridae” (S. G. Siddell, ed.), pp. 141- 163. New York: Plenum Press,

Lauer, S.A., Grantz, K.H., Bi.  Q.J., Forrest, K., Zheng, Q., Meredith, H.R., Azman,  A.S., Reich,  N.G. (2020).The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine, Archived  from the original on 24 March 2020.

 Lei, J. J., Li, X., Li, X., Qi, C.T. (2020). Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia, Radiology, 200236

Letko, M., Marzi, A., Munster, V. (2020).Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol.

Li, B., Si, H-R., Zhu, Y., Yang, X-L., Anderson, D.E., Shi, Z-L., et al. (2020).  Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing. mSphere, 5(1). 

Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol.3, 237- 261

Li, F., Li, W., Farzan, M., Harrison, S.C. (2005). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 309, 1864-1868

Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019 – nCoV). Nat Rev Drug Discov, 19, 149 -150 

Li, G., Chen, X., Xu, A. (2003). Profile of specific antibodies to the SARS-associated coronavirus.  N Engl J Med, 349, 508-509

Lim, Y.X., Ng, Y.L., Tam, J.P., Liu, D.X. (2016). Human coronaviruses: a review of virus–host interactions. Diseases, 4(3): 26.

Ling, L., Lianfeng, L., Wei, C.,Taisheng, L. (2020). Hypothesis for potential pathogenesis of SARS- CoV-2 infection a review of immune changes in patients with viral pneumonia. Review.Emerging Microbes and  Infections, Vol. 9

Liu, S.L., & Saif, L. (2020): Emerging Viruses without Borders: The Wuhan coronavirus. Viruses, 12(2). https://doi.org/10.3390/v12020130

Liu, Y.C., Liao, C.H., Chang, C.F., Chou, C.C., Lin, Y.R. (2020). A locally transmitted Case of SARS-CoV-2 infection in Taiwan. N Engl J Med. 2020 Feb 12.  

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al., (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224), 565–74.

Macarthur, G. (2009). Global health diagnostics: research, development and regulation. Academy of Medical Sciences Workshop Report (PDF). Academy of Medical Sciences (Great Britain).   Archived from the original (PDF) on 2018-05-16. Retrieved 2014-05-05.

Mahdi, A.O.,  Parham, M., Ehsaneh, K.h., S. ükran Köse, Isabella, E., Khudaverdi, G., et al. (2020). Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period: Review.Le Infezioni in Medicina, n. 2, 153-165

Malik, Y.S., Sircar, S., Bhat, S., Sharun, K., Dhama, K., Dadar, M., Tiwari, R., Chaicumpa, W. (2020). Emerging novel Coronavirus (2019-nCoV)-Current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q, 40, 68-76.

Matsuyama, S. et al. (2010).Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol, 84, 12658–12664

Meyer, N.J., Christie, J.D. (2013). Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 34:  459- 474.

Michael, L., Andrea, M., Vincent, M. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology, 5, 562–569

Mori, Y., Kitao, M., Tomita, N., Notomi, T. (2004). Real- time turbidimetry of LAMP reaction for quantifying template DNA. J Biochem Biophys  Methods, 59 (2), 145- 57

Mori, Y., Nagamine, K., Tomita, N., Notomi, T. (2001). Detection of loop- mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res  Commun, 289 (1), 150- 4

Morse, J.S., Lalonde, T., Shiqing, X., Liu, W.R. (2020). Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chem Bio Chem.

Mullins. E., Evans, D., Viner, R.M., O’Brien, P., Morris, E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound in Obstetrics and Gynecology. n /a(n/a).

Munster, V.J., Koopmans, M., van Doremalen, N., van Riel, D., de Wit, E. (2020). A novel Coronavirus emerging in China-key questions for impact assessment. N. Engl J Med. 10.1056/NEJMp2000929.

Nagamine, K., Hase, T., Notomi, T. (2002). Accelerated reaction by loop- mediated isothermal amplification using loop primers. Mol Cell Probes. 16 (3), 223- 9

National Health Commission of China (2020). Guideline for diagnosis and treatment for novel coronavirus pneumonia (5th ed). http://www.nhc.gov.cn/xcs/zhengcwj/   (Accessed 4 February 2020). 

National Institutes of Health. New coronavirus stable for hours on surfaces 17 March 2020. Archived from the original on 23 March 2020. Retrieved 23 March 2020.

 Neil, M.F., Daniel, L., Gemma, N- G., Natsuko, I., Kylie, A., Marc, B., et al. (2020).  Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand: Imperial College COVID-19 Response Team; 2020 [16 March, 2020].

Ng,  D.L., Al Hosani,  F., Keating,  M.K., Gerber,  S.I., Jones, T.L., Metcalfe, M.G. et al. (2016). Clinicopathologic, Immunohistochemical and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014. Am. J. Pathol, 186, 652- 658

Nishiura, H., Linton, N.M., Akhmetzhanov, A.R. (2020). Serial interval of novel coronavirus (COVID-19) infections. International Journal of Infectious Diseases.

Njiru, Z.K., Mikosza, A.S., Armstrong, T., Enyaru, J.C., Ndung’u, J.M., Thompson, A.R. (2008).  Loop- mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense. PLOS Negl Trop Dis, 2 (1), e147  

Noh, J.Y., Yoon, S-W., Kim, D-J., et al. (2017). Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome and related bat coronaviruses by real-time reverse transcription PCR. Arch virol. 162, 1617- 23

Notomi, T., Okayama, H., Masubuchi, H., et al. (2000). Loop- mediated isothermal amplification of DNA. Nucl Acid Res. 28: e63- e

 Pan, Y., Guan, H., Zhou, S., et al. (2020). Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019- nCoV): a study of 63 patients in Wuhan, China, Eur Radiol.

Peng, L., Liu, J., Xu, W., et al. (2020). 2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples. Med Rxiv.

Poon, L.L., Leung, C.S., Tashiro, M., et al. (2004). Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop- mediated isothermal amplification assay. Clin Chem. 50, 1050- 2

Qian, G-Q., Yang, N-B., Ding, F. et al. (2020). Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. Med Rxiv. 

Rodriguez-Morales, A.J., MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. (2020). Going global – Travel and the 2019 novel coronavirus. Travel Med Infect Dis. 33, 101578.

 Rothan, H.A., Siddappa, N. Byrareddy (2020).  Journal of Autoimmunity, https://doi.org/10.1016/j.jaut.2020.102433

Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al.(2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med.2020 Jan 30.

Ranjan, A., Chauhan, A., Gurnani,, M., & Jindal, T. (2020). Potential phytochemicals as efficient protease inhibitors of 2019-nCoV . Preprints 2020, 2020040240 (doi: 10.20944/preprints202004.0240.v1).

Salehi, S., Abedi, A., Balakrishnan, S., Gholamrezanezhad. A. (2020). Coronavirus Disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. [Epub ahead of print]. American Journal of Roentgenology, 1- 7

Sen, K., Ashbolt, N.J. (2011). Environmental microbiology: current technology and water application. Norfolk, UK: Caister Academic Press.

Setianingsih, T.Y., Wiyatno, A., Hartono, T.S. et al. (2019). Detection of multiple viral sequences in the respiratory tract samples of suspected Middle East respiratory syndrome coronavirus patients in Jakarta, Indonesia 2015–2016. Intern J Infect Dis, 86, 102-7

Shen, S., Wen, Z. L., and Liu, D. X. (2003). Emergence of a coronavirus infectious bronchitis virus mutant with a truncated 3b gene: Functional characterization of the 3b protein in pathogenesis and replication. Virology, 311, 16–27.

Shulla, A. et al. (2011). A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol, 85, 873- 882

Simmons.  G., Zmora, P., Gierer, S., Heurich.  A., Pohlmann, S. (2013). Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res.100, 605- 614

Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., et al. (2019): From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1), E59.

Stockman, L.J., Bellamy, R., Garner, P. (2006). SARS: Systematic review of treatment effects. PLoS Med. 3(9), e343

Takada, A., Kawaoka, Y. (2003). Antibody- dependent enhancement of viral infection: Molecular mechanisms and in vivo implications. Rev Med Virol. 13, 387- 398

Takeuchi, O., Akira, S. (2009). Innate immunity to virus infection. Immunol Rev. 227(1), 75- 86. 

Tang, B., Wang, X., Li, Q. et al. (2020). Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med.  9,  462

Thompson, B.T., Chambers, R.C., Liu, K.D. (2017). Acute Respiratory Distress Syndrome. N   Engl J Med. 377, 562–572.

 To, K.K., Tsang, O.T., Chik-Yan, Yip, C., Chan, K.H., Wu, T.C., Chan, J.M., et al.(2020). Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020.

Tomita, N., Mori, Y., Kanda, H., Notomi, T. (2008). Loop- mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat Protoc. 3 (5), 877- 82  

Tortorici, M.A., Veesler, D. (2019): Structural insights into coronavirus entry. Adv Virus Res. 105, 93–116.

 Uhlenhaut, C., Cohen, J.I., Pavletic, S., et al. (2012). Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia. Transp Infect Dis. 14, 79-85 

van Boheemen. S., de Graaf. M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., et al. (2012). Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 3(6), e00473-12. 

van Doremalen, N., Bushmaker, T., Morris, D.H., Holbrook, M.G., Gamble, A. et al. (2020).  Aerosol and surface stability of SARS-CoV-2 compared with SARS-CoV-1. New England Journal of Medicine: NEJMc. 2004973

Wan, Y., Shang, J., Graham, R., Baric, R.S., Li, F. (2020). Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. Journal of virology.

Wan, Z., Zhang, Y.n., He, Z., et al. (2016). A Melting Curve- Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses. Intern J Mol Sci. 17, 1880

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3), 269–71. doi: 10.1038/s41422-020-0282-0. 

Wang, S., Guo, L., Chen, L., Liu, W., Cao, Y., Zhang, J., et al.(2020). A case report of neonatal COVID-19 infection in China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020 Mar 12.

Weiss, S.R., Leibowitz, J.L. (2011). Coronavirus pathogenesis. In: Advances in virus research. edn. Elsevier, 81, 85-164.

World Health Organization (b) (2020). Home care for patients with suspected novel infection presenting with mild symptoms and management of their contacts: interim guidance, 04 February 2020. 

World Health Organization (c) (2020). Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim guidance. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infectionwhen- novel-coronavirus-(ncov)-infection-is-suspected. (Accessed 13). March 2020. 

World Health Organization .Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?Archived from the original on 20 January 2020. 

Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.L., Abiona, O., et al. (2020).  

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science

Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., et al. (2020). Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe.

Wu, J., Chen, Z.J. (2014). Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 32, 461- 88.

Wu, Z., McGoogan, J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; (Epub ahead of print).

 Xiao, F., Tang,  M., Zheng,  X., Li,  C., He, J., Hong,  Z., Huang,  S., Zhang, Z., Lin,  X., Fang,  Z., et al. (2020).Evidence for gastrointestinal infection of SARS-CoV-2. Med Rxiv.

Xie, C., Jiang, L., Huang, G., Pu, H., Gong, B., Lin, H., Ma, S., Chen, X. et al. (2020). Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 93, 264- 267.

Xie, J., Fan, H.W., Li, T.S., et al. (2006). Dynamic changes of T lymphocyte subsets in the long- term follow-up of severe acute respiratory syndrome patients. Chinese Acad Med Sci. 28(2), 253- 255

Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., et al. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 1-4

Yam, W.C.,  Chan, K.H., Poon, L.L. et al. (2003). Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus, J. Clin. Microbiol. 41, 4521- 4524

Yang, M. (2020). Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection. SSRN

Yan-Rong, G., Qing-Dong, C., Zhong-Si, H., Yuan-Yang, T., Shou-Deng, C., Hong-Jun, J., Kai-Sen, T., De-Yun, W. and Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research, 7, 11 

Yuefei, J., Haiyan, Y., Wangquan, J., Weidong, W., Shuaiyin, Ch., Weiguo, Zh.  Guangcai, D. (2020). Virology, Epidemiology, Pathogenesis, and Control of COVID-19: Review. Viruses, 12, 372.  pp 2-17

Yujuan, X., Zhen-Zhen, L., Qi-Zhen, Z., Yan, C., Fei, L., Yi-Yuan, G., Yi, W., Pei-Feng, K., Xian-Zhang, H. (2020). Comparative performance of four nucleic acid amplification tests for SARS – CoV-2 virus. April 2020. 

Zhang, L., Shen, F.M., Chen, F., Lin, Z. (2020). Origin and evolution of the 2019 novel coronavirus. Clin Infect Dis.

Zhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan. K., et al., (2003). Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. The Lancet, 362(9393), 1353-8. 

Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature

Zhu, H., Wang, L., Fang, C., Peng, S., Zhang, L. et al. (2020).  Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics. 9(1), 51-60.

Zumla, A. et al. (2016). Coronaviruses – drug discovery and therapeutic options. Nat. Rev. Drug Discov, 15, 327–347.

License                      Article Metadata

This work is licensed under a Creative Commons Attribution 4.0 International License.